WEST PHARMACEUTICAL SERVICES INC financial data

Symbol
WST on NYSE
Location
Exton, PA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 17 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 287% % 7.5%
Quick Ratio 70% % 0.84%
Debt-to-equity 35% % -0.26%
Return On Assets 12% % -9.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 72,021,491 shares -0.39%
Common Stock, Shares, Outstanding 72,000,000 shares -0.42%
Entity Public Float $15,700,000,000 USD -34%
Common Stock, Value, Issued $18,800,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 72,300,000 shares -0.96%
Weighted Average Number of Shares Outstanding, Diluted 72,700,000 shares -1.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $695,400,000 USD -3%
Revenue from Contract with Customer, Excluding Assessed Tax $3,074,100,000 USD 6.3%
Research and Development Expense $74,300,000 USD 7.5%
Operating Income (Loss) $584,900,000 USD 2.6%
Nonoperating Income (Expense) $17,600,000 USD 28%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $600,900,000 USD 2.6%
Income Tax Expense (Benefit) $121,600,000 USD 13%
Net Income (Loss) Attributable to Parent $493,700,000 USD 0.2%
Earnings Per Share, Basic 6.83 USD/shares 1.2%
Earnings Per Share, Diluted 6.79 USD/shares 1.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $791,300,000 USD 63%
Accounts Receivable, after Allowance for Credit Loss, Current $574,400,000 USD 4%
Inventory, Net $443,900,000 USD 18%
Other Assets, Current $168,600,000 USD 36%
Assets, Current $1,978,200,000 USD 29%
Deferred Income Tax Assets, Net $38,400,000 USD 48%
Property, Plant and Equipment, Net $1,726,400,000 USD 9.2%
Operating Lease, Right-of-Use Asset $117,000,000 USD 12%
Intangible Assets, Net (Excluding Goodwill) $7,700,000 USD -29%
Goodwill $109,900,000 USD 3.7%
Other Assets, Noncurrent $80,100,000 USD 7.8%
Assets $4,270,000,000 USD 17%
Accounts Payable, Current $253,700,000 USD 6%
Liabilities, Current $654,900,000 USD 19%
Deferred Income Tax Liabilities, Net $23,000,000 USD 12%
Operating Lease, Liability, Noncurrent $95,600,000 USD 17%
Other Liabilities, Noncurrent $75,200,000 USD 21%
Liabilities $1,094,000,000 USD 14%
Accumulated Other Comprehensive Income (Loss), Net of Tax $105,500,000 USD 59%
Retained Earnings (Accumulated Deficit) $4,374,900,000 USD 11%
Stockholders' Equity Attributable to Parent $3,176,000,000 USD 18%
Liabilities and Equity $4,270,000,000 USD 17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $129,400,000 USD 9.5%
Net Cash Provided by (Used in) Financing Activities $147,000,000 USD 46%
Net Cash Provided by (Used in) Investing Activities $71,300,000 USD 21%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 75,300,000 shares 0%
Common Stock, Par or Stated Value Per Share 0.25 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $80,400,000 USD 68%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $791,300,000 USD 63%
Deferred Tax Assets, Valuation Allowance $16,200,000 USD 27%
Operating Lease, Liability $118,300,000 USD 19%
Depreciation $39,100,000 USD 13%
Payments to Acquire Property, Plant, and Equipment $71,300,000 USD -21%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $646,300,000 USD 71%
Lessee, Operating Lease, Liability, to be Paid $146,400,000 USD 29%
Property, Plant and Equipment, Gross $3,223,400,000 USD 8%
Operating Lease, Liability, Current $22,700,000 USD 27%
Lessee, Operating Lease, Liability, to be Paid, Year Two $21,000,000 USD 1.4%
Lessee, Operating Lease, Liability, to be Paid, Year One $27,400,000 USD 17%
Operating Lease, Weighted Average Discount Rate, Percent 0.0467 pure 17%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $28,100,000 USD 110%
Lessee, Operating Lease, Liability, to be Paid, Year Three $20,100,000 USD 23%
Deferred Tax Assets, Operating Loss Carryforwards $3,200,000 USD -48%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 3,000,000 shares 0%
Unrecognized Tax Benefits $56,100,000 USD 29%
Lessee, Operating Lease, Liability, to be Paid, Year Four $14,800,000 USD -0.67%
Operating Lease, Payments $6,100,000 USD 15%
Additional Paid in Capital $0 USD -100%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $171,400,000 USD 10%
Deferred Tax Assets, Net of Valuation Allowance $114,100,000 USD 22%
Share-based Payment Arrangement, Expense $23,800,000 USD 27%
Interest Expense $700,000 USD -76%